Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$287,424,866
-$17,074,331 QoQ
Shares Held
578,634
-15.1% QoQ
Ownership
0.228%
of shares outstanding
% of Portfolio
6.22%
of 13F equity value
Holder Rank
#51
of 1,732 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. VRTX ranks #1 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
6,185,970 | $115,739,498 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $287,424,866 | 578,634 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $304,499,197 | 681,908 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $308,792,563 | 681,120 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $198,093,470 | 505,805 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $196,604,771 | 441,610 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $200,265,082 | 413,071 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $196,289,671 | 487,434 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $265,749,502 | 571,406 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $278,167,039 | 593,461 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $279,544,187 | 668,750 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $299,629,727 | 736,390 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $348,691,068 | 1,002,735 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $386,103,686 | 1,097,166 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $360,974,122 | 1,145,695 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $316,510,964 | 1,096,028 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $335,323,801 | 1,158,126 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $331,423,362 | 1,176,136 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $386,301,625 | 1,480,253 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $393,470,715 | 1,791,761 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $319,539,526 | 1,761,616 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $349,564,721 | 1,733,694 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $295,839,922 | 1,376,704 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $292,821,714 | 1,238,985 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $261,398,472 | 960,600 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $285,258,606 | 982,600 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $302,931,527 | 1,273,089 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||